Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
It may take a minute or two
Note: The use of binary terms such as male and female or men and women in this article reflects the language of the sources weve used
Over time, the enhanced metabolic efficiency can increase energy levels and overall body composition
LY3437943 (Retatrutide): discovery to clinical proof of concept (triple GLP-1/GIP/glucagon agonist, preclinical mechanism) Nature Reviews Endocrinology (2024) Multi-receptor agonists for metabolic disease (mechanism of GLP-1/GIP/glucagon co-activation) Diabetes Care (2024) Incretin-based therapies: GLP-1, GIP, and glucagon receptor pharmacology (metabolic pathways, energy expenditure) NEJM (2023) Supplementary Material Jastreboff et al
US$ 20.69
US$ 24.73
US$ 26.40
US$ 29.32
US$ 21.52
US$ 23.65
